Presence of maternal anti-HBs antibodies does not influence hepatitis B vaccine response in Brazilian neonates

Memórias do Instituto Oswaldo Cruz

Ana Luiza N Junqueira²  Viviane R Tavares²  Regina Mb Martins¹  Kamilla V Frauzino²  Agabo M Da Costa E Silva¹  Izolina Mx Rodrigues¹  Ruth Minamisava²  Sheila A Teles² 

[1] ,Faculdade de Enfermagem

关键词: hepatitis B vaccine;    newborn infants;    antibody response;   

DOI  :  10.1590/S0074-02762011000100018

来源: SciELO

【 摘 要 】

Recently, it was suggested that maternal hepatitis B surface antigen antibodies (anti-HBs) acquired transplacentally could play a negative role in newborn infants' immune response to the hepatitis B vaccine. We compared the hepatitis B virus (HBV) vaccine response in infants born to mothers previously vaccinated against HBV (n = 91) to infants born to mothers who were not previously vaccinated (n = 221). All newborn infants received three intramuscular doses (10 μg) of HBV vaccine (Butang®) at 0,1 and six months. The first dose was administered at the maternity hospital within 12 h of birth. The geometric mean titres of anti-HBs were not different among newborn infants born to mothers who were anti-HBs-negative (492.7 mIU/mL) and anti-HBs-positive (578.7 mIU/mL) (p = 0.38). Eight infants did not respond to the HBV vaccine. Of them, six were born to anti-HBs-negative mothers and two were born to mothers with anti-HBs titres less than 50 mlU/mL. Despite the mother's anti-HBs-positive status, our data show a good immunogenicity of the Brazilian HBV recombinant vaccine in neonates.

【 授权许可】

CC BY   
 All the contents of this journal, except where otherwise noted, is licensed under a Creative Commons Attribution License